Skip to main content
Fig. 7 | Orphanet Journal of Rare Diseases

Fig. 7

From: Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial

Fig. 7

a IGF-I SDS over time b IGFBP-3 SDS over time. The lower and upper boundaries are the 25th percentile and 75th percentile, respectively. The horizontal line in the box shows the median. Filled squares are mean values. IGF-I, insulin-like growth factor I; SDS, standard deviation score; IGFBP-3, IGF-binding protein 3

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172